| Literature DB >> 30591745 |
A M Abdelhalem1, A M Shabana2, A M Onsy2, A E Gaafar1.
Abstract
BACKGROUND: Exercise-based Cardiac rehabilitation (CR) plays a major role in reducing mortality and morbidity in patients with coronary artery disease (CAD). The standard protocol is usually of moderate intensity exercise. High-intensity interval training (HIIT) consists of alternating periods of intensive aerobic exercise with periods of passive or active moderate/mild intensity recovery. AIM: This study aimed to assess HIIT program for ischemic patients attending CR after percutaneous coronary intervention (PCI) who have mild left ventricular dysfunction and to compare its effect on the functional capacity and quality of life with standard exercise CR program. PATIENTS AND METHODS: Our study included 40 patients with documented CAD, who participated in the outpatient CR program in Ain Shams University hospital (Al-Demerdash Hospital) divided into two equal groups, each included 20 patients. Group A included the patients who underwent standard cardiac rehabilitation program, while group B joined the high intensity interval training exercise protocol.Entities:
Keywords: Cardiac rehabilitation; Egyptian; High intensity interval training; Left ventricular dysfunction
Year: 2018 PMID: 30591745 PMCID: PMC6303527 DOI: 10.1016/j.ehj.2018.07.008
Source DB: PubMed Journal: Egypt Heart J ISSN: 1110-2608
The demographic data, risk factors and initial laboratory results of the two groups.
| Demographic data/risk factors/labs | Group A | Group B | Independent | ||
|---|---|---|---|---|---|
| n = 20 | n = 20 | t | P-value | ||
| Age (years) | Mean ± SD | 51.95 ± 8.07 | 54.65 ± 7.63 | −1.087 | 0.284 |
| Range | 38 –67 | 35–65 | |||
| Gender | Male | 16 (80%) | 18 (90%) | 0.784* | 0.376 |
| Female | 4 (20%) | 2 (10%) | |||
| Weight (Kg) | Mean ± SD | 81.00 ± 8.86 | 84.85 ± 14.14 | −1.032 | 0.309 |
| Range | 58–95 | 58–114 | |||
| Height (cm) | Mean ± SD | 166.15 ± 6.13 | 167.45 ± 6.85 | −0.632 | 0.531 |
| Range | 155–173 | 155–180 | |||
| Hypertension | 6 (30%) | 7 (35%) | 0.114 | 0.736 | |
| Diabetes mellitus | 9 (45%) | 6 (30%) | 0.960 | 0.327 | |
| Dyslipidemia | 2 (10%) | 3 (15%) | 0.229 | 0.633 | |
| Smoking | Non-Smoker | 10 (50%) | 7 (35%) | 1.815 | 0.404 |
| Smoker | 8 (40%) | 8 (40%) | |||
| Ex-Smoker | 2 (10%) | 5 (25%) | |||
| s. Creatinine (mg/dl) | Mean ± SD | 1.00 ± 0.20 | 1.27 ± 0.32 | −3.127 | 0.003 |
| Range | 0.70–1.40 | 0.80–2.20 | |||
| Hb (gm/dl) | Mean ± SD | 12.18 ± 1.46 | 12.82 ± 1.35 | −1.440 | 0.158 |
| Range | 8.70–15.20 | 10.00–15.50 | |||
| Platelet count | Mean ± SD | 250.40 ± 82.73 | 244.45 ± 58.17 | 0.263 | 0.794 |
| Range | 136–463 | 155–361 | |||
| WBCs (×109/L) | Mean ± SD | 7.31 ± 2.20 | 8.72 ± 2.69 | −1.817 | 0.077 |
| Range | 4.40–14.40 | 4.10–13.90 | |||
| s. Cholesterol (mg/dl) | Mean ± SD | 168.25 ± 44.92 | 185.70 ± 23.46 | −1.540 | 0.132 |
| Range | 97–250 | 119–220 | |||
| LDL (mg/dl) | Mean ± SD | 105.95 ± 22.78 | 94.45 ± 15.41 | 1.870 | 0.069 |
| Range | 67–142 | 59–123 | |||
| HDL (mg/dl) | Mean ± SD | 40.28 ± 13.91 | 35.05 ± 4.49 | 1.599 | 0.118 |
| Range | 27–95 | 24–48 | |||
| s. TGs (mg/dl) | Mean ± SD | 119.35 ± 47.98 | 138.60 ± 33.47 | −1.472 | 0.149 |
| Range | 36–258 | 95–212 | |||
| Culprit PCI arteries | Group A | Group B | Chi-square test | ||
| n = 20 | n = 20 | X | P-value | ||
| Artery | LAD | 14 (70%) | 13 (65%) | 4.370 | 0.627 |
| LCX | 1 (5%) | 0 (0%) | |||
| RCA | 3 (15%) | 3 (15%) | |||
| LAD, LCX | 1 (5%) | 2 (10%) | |||
| LAD, RCA | 1 (5%) | 0 (0%) | |||
| LCX, RCA | 0 (0%) | 1 (5%) | |||
| LAD, LCX and RCA | 0 (0%) | 1 (5%) | |||
| Stent type | BMS | 15 (75%) | 15 (75%) | 0.000 | 1.000 |
| DES | 5 (25%) | 5 (20%) | |||
| TIMI flow | 3 | 20 (100%) | 20 (100%) | – | – |
BMS: bare metal stent, DES: drug-eluting stent Hb: hemoglobin level, HDL: high density lipoprotein cholesterol, LAD: Left anterior descending artery, Lcx: left circumflex artery, LDL: low density lipoprotein cholesterol, PCI: percutaneous coronary angioplasty, RCA right coronary artery, Sd: standard deviation, TIMI flow: Thrombolysis In Myocardial Infarction trial flow grades, TGs: Triglycerides, WBCs = white blood cell count.
Comparison between the two groups regarding functional capacity (METS) achieved by exercise test, Left ventricular function assessed by echocardiography and the quality of life questionnaire (RAND score).
| Initial Exercise/echocrdiogrphy | Group A | Group B | Independent | ||
|---|---|---|---|---|---|
| n = 20 | n = 20 | T | P-value | ||
| METS | Mean ± SD | 8.35 ± 2.06 | 7.60 ± 2.14 | 1.130 | 0.265 |
| Range | 5–12 | 5–11 | |||
| EF% | Mean ± SD | 43.85 ± 5.30 | 43.30 ± 5.32 | 0.327 | 0.745 |
| Range | 35–50 | 35–50 | |||
| General health | Mean ± SD | 256.25 ± 29.10 | 253.75 ± 24.70 | 0.293 | 0.771 |
| Range | 200–300 | 225–300 | |||
| Physical function | Mean ± SD | 637.50 ± 42.53 | 625.00 ± 34.41 | 1.022 | 0.313 |
| Range | 550–700 | 550–700 | |||
| Emotional wellbeing | Mean ± SD | 273.00 ± 31.97 | 283.00 ± 20.80 | −1.173 | 0.248 |
| Range | 220 –320 | 240–320 | |||
| TOTAL score | Mean ± SD | 1781.25 ± 121.37 | 1832.50 ± 109.85 | −1.400 | 0.170 |
| Range | 1660–2060 | 1660–2000 | |||
METS: metabolic equivalents, EF: Ejection fraction, QOL: quality of life, SD: standard deviation.
Showing the results of group A patients before and after cardiac rehabilitation (CR).
| Group A | Paired | ||||
|---|---|---|---|---|---|
| Pre-CR | Post-CR | T | P-value | ||
| METS | Mean ± SD | 8.35 ± 2.06 | 10.90 ± 2.65 | −6.168 | 0.000 |
| Range | 5–12 | 5–14 | |||
| EF% | Mean ± SD | 43.85 ± 5.30 | 48.25 ± 5.44 | −5.100 | 0.000 |
| Range | 35–50 | 40–57 | |||
| General health | Mean ± SD | 256.25 ± 29.10 | 356.25 ± 31.28 | −13.784 | 0.000 |
| Range | 200–300 | 275–400 | |||
| Physical function | Mean ± SD | 637.50 ± 42.53 | 757.50 ± 40.64 | −10.258 | 0.000 |
| Range | 550–700 | 650–800 | |||
| Emotional wellbeing | Mean ± SD | 273.00 ± 31.97 | 377.00 ± 31.30 | −12.185 | 0.000 |
| Range | 220 –320 | 300–420 | |||
| TOTAL | Mean ± SD | 1781.25 ± 121.37 | 2967.25 ± 84.03 | −44.441 | 0.000 |
| Range | 1660–2060 | 2820–3120 | |||
| s. Creatinine (mg/dl) | Mean ± SD | 1.00 ± 0.20 | 0.99 ± 0.17 | 0.312 | 0.759 |
| Range | 0.70–1.40 | 0.70–1.50 | |||
| Hb (gm/dl) | Mean ± SD | 12.18 ± 1.46 | 12.14 ± 1.18 | 0.309 | 0.761 |
| Range | 8.70–15.20 | 9–15 | |||
| Platelet count | Mean ± SD | 250.40 ± 82.73 | 251.80 ± 76.62 | −0.207 | 0.838 |
| Range | 136–463 | 140–400 | |||
| WBCs (×109/L) | Mean ± SD | 7.31 ± 2.20 | 6.82 ± 1.44 | 1.354 | 0.192 |
| Range | 4.40–14.40 | 4–10 | |||
| s. Cholesterol (mg/dl) | Mean ± SD | 168.25 ± 44.92 | 151.20 ± 45.75 | 4.123 | 0.001 |
| Range | 97–250 | 74–222 | |||
| LDL (mg/dl) | Mean ± SD | 105.95 ± 22.78 | 92.41 ± 26.72 | 2.565 | 0.019 |
| Range | 67–142 | 40–140 | |||
| HDL (mg/dl) | Mean ± SD | 40.28 ± 13.91 | 37.80 ± 6.61 | 0.731 | 0.474 |
| Range | 27–95 | 27–48 | |||
| s. TGs (mg/dl) | Mean ± SD | 119.35 ± 47.98 | 103.40 ± 35.08 | 2.246 | 0.037 |
| Range | 36–258 | 64–206 | |||
EF: Ejection fraction, Hb: hemoglobin level, HDL: high density lipoprotein cholesterol, METS: metabolic equivalents, QOL: quality of life, SD: standard deviation, TGs: Triglycerides, WBCs = white blood cell count.
Showing the results of group B patients before and after cardiac rehabilitation (CR).
| Group B | Paired | ||||
|---|---|---|---|---|---|
| Pre-CR | Post-CR | T | P-value | ||
| METS | Mean ± SD | 7.60 ± 2.14 | 11.55 ± 1.47 | −12.338 | 0.000 |
| Range | 5–11 | 10–14 | |||
| EF% | Mean ± SD | 43.30 ± 5.32 | 48.30 ± 5.72 | −5.590 | 0.000 |
| Range | 35–50 | 38–60 | |||
| General health | Mean ± SD | 253.75 ± 24.70 | 345.00 ± 33.05 | −12.873 | 0.000 |
| Range | 225–300 | 275–400 | |||
| Physical function | Mean ± SD | 625.00 ± 34.41 | 747.50 ± 41.28 | −9.969 | 0.000 |
| Range | 550–700 | 650–850 | |||
| Emotional wellbeing | Mean ± SD | 283.00 ± 20.80 | 398.00 ± 15.76 | −19.892 | 0.000 |
| Range | 240–320 | 380–420 | |||
| TOTAL | Mean ± SD | 1832.50 ± 109.85 | 3026.50 ± 79.08 | −47.777 | 0.000 |
| Range | 1660–2000 | 2900–3200 | |||
| s. Creatinine (mg/dl) | Mean ± SD | 1.27 ± 0.32 | 1.09 ± 0.26 | 5.181 | 0.000 |
| Range | 0.80–2.20 | 0.67–2.00 | |||
| Hb (gm/dl) | Mean ± SD | 12.82 ± 1.35 | 13.23 ± 2.59 | −0.825 | 0.419 |
| Range | 10.00–15.50 | 10–23 | |||
| Platelet count | Mean ± SD | 244.45 ± 58.17 | 232.25 ± 50.35 | 3.893 | 0.001 |
| Range | 155–361 | 150–333 | |||
| WBCs (×109/L) | Mean ± SD | 8.72 ± 2.69 | 6.45 ± 1.43 | 6.047 | 0.000 |
| Range | 4.10–13.90 | 4–10 | |||
| s. Cholesterol (mg/dl) | Mean ± SD | 185.70 ± 23.46 | 163.90 ± 20.57 | 8.460 | 0.000 |
| Range | 119–220 | 110–200 | |||
| LDL (mg/dl) | Mean ± SD | 94.45 ± 15.41 | 84.45 ± 11.56 | 6.056 | 0.000 |
| Range | 59–123 | 62–110 | |||
| HDL (mg/dl) | Mean ± SD | 35.05 ± 4.49 | 41.00 ± 3.83 | −9.568 | 0.000 |
| Range | 24–48 | 30–50 | |||
| s. TGs (mg/dl) | Mean ± SD | 138.60 ± 33.47 | 118.95 ± 27.02 | 8.718 | 0.000 |
| Range | 95–212 | 83–170 | |||
EF: Ejection fraction, Hb: hemoglobin level, HDL: high density lipoprotein cholesterol, METS: metabolic equivalents, QOL: quality of life, SD: standard deviation, TGs: Triglycerides, WBCs = white blood cell count.
Fig. 1Comparison between METS pre and post rehabilitation in group A.
Fig. 2Comparison between QOL questionnaire pre and post rehabilitation in group A.
Fig. 3Comparison between METS before and after rehabilitation in group B.
Fig. 4QOL questionnaire before and after rehabilitation in group B.
Comparison between groups A and B post cardiac rehabilitation.
| Group A | Group B | Independent | |||
|---|---|---|---|---|---|
| n = 20 | n = 20 | T | P-value | ||
| METS | Mean ± SD | 10.90 ± 2.65 | 11.55 ± 1.47 | −0.959 | 0.344 |
| Range | 5–14 | 10–14 | |||
| EF% | Mean ± SD | 48.25 ± 5.44 | 48.30 ± 5.72 | −0.028 | 0.978 |
| Range | 40–57 | 38–60 | |||
| General health | Mean ± SD | 356.25 ± 31.28 | 345.00 ± 33.05 | 1.106 | 0.276 |
| Range | 275–400 | 275–400 | |||
| Physical function | Mean ± SD | 757.50 ± 40.64 | 747.50 ± 41.28 | 0.772 | 0.445 |
| Range | 650–800 | 650–850 | |||
| Emotional wellbeing | Mean ± SD | 377.00 ± 31.30 | 398.00 ± 15.76 | −2.680 | 0.011 |
| Range | 300–420 | 380–420 | |||
| TOTAL | Mean ± SD | 2967.25 ± 84.03 | 3026.50 ± 79.08 | −2.296 | 0.027 |
| Range | 2820–3120 | 2900–3200 | |||
| s. Creatinine (mg/dl) | Mean ± SD | 0.99 ± 0.17 | 1.09 ± 0.26 | −1.517 | 0.137 |
| Range | 0.70–1.50 | 0.67–2.00 | |||
| Hb (gm/dl) | Mean ± SD | 12.14 ± 1.18 | 13.23 ± 2.59 | −1.712 | 0.095 |
| Range | 9–15 | 10–23 | |||
| Platelet count | Mean ± SD | 251.80 ± 76.62 | 232.25 ± 50.35 | 0.954 | 0.346 |
| Range | 140–400 | 150–333 | |||
| WBCs(× 109/L) | Mean ± SD | 6.82 ± 1.44 | 6.45 ± 1.43 | 0.805 | 0.426 |
| Range | 4–10 | 4–10 | |||
| s. Cholesterol (mg/dl) | Mean ± SD | 151.20 ± 45.75 | 163.90 ± 20.57 | −1.132 | 0.265 |
| Range | 74–222 | 110–200 | |||
| LDL (mg/dl) | Mean ± SD | 92.41 ± 26.72 | 84.45 ± 11.56 | 1.223 | 0.229 |
| Range | 40–140 | 62–110 | |||
| HDL (mg/dl) | Mean ± SD | 37.80 ± 6.61 | 41.00 ± 3.83 | −1.875 | 0.069 |
| Range | 27–48 | 30–50 | |||
| s. TGs (mg/dl) | Mean ± SD | 103.40 ± 35.08 | 118.95 ± 27.02 | −1.571 | 0.125 |
| Range | 64–206 | 83–170 | |||
EF: Ejection fraction, Hb: hemoglobin level, HDL: high density lipoprotein cholesterol, METS: metabolic equivalents, QOL: quality of life, SD: standard deviation, TGs: Triglycerides, WBCs = white blood cell count.